ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 14, 2018.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July 26, 2018, Specgx, LLC, 3600 North Second Street, Saint Louis, Missouri 63147-3457 applied to be registered as a bulk manufacturer of the following basic class of controlled substance:
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters, and ethers | 9850 | I |
The company plans to manufacture the above-listed controlled substance in gram quantities for sale as analytical research standards.
Dated: September 24, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-22415 Filed 10-12-18; 8:45 am]
BILLING CODE 4410-09-P